Results 191 to 200 of about 105,810 (308)

Emergence of highly profibrotic and proinflammatory Lrat+Fbln2+ HSC subpopulation in alcoholic hepatitis

Hepatology, EarlyView., 2022
Lrat+ quiescent hepatic stellate cells (qHSC) give rise to Lrat+Fbln2+ activated HSC (aHSC) in alcohol‐associated hepatitis and this subpopulation is highly profibrotic, inflammatory, and immunoregulatory based on their single cell transcriptomic profile. Abstract Background and Aims Relative roles of HSCs and portal fibroblasts in alcoholic hepatitis (
Steven Balog, Reika Fujiwara, Stephanie Q. Pan, Khairat B. El‐Baradie, Hye Yeon Choi, Sonal Sinha, Qihong Yang, Kinji Asahina, Yibu Chen, Meng Li, Matthew Salomon, Stanley W.‐K. Ng, Hidekazu Tsukamoto   +12 more
wiley   +1 more source

Expression of Tissue Inhibitors of Metalloproteinases (TIMP-1, TIMP-2, TIMP-3, TIMP-4) in Blood Serum of Patients with Keratoconus. [PDF]

J Clin Med
Nowak-Wąs M, Wąs P, Czuba Z, Wojnicz R, Wyględowska-Promieńska D.   +4 more
europepmc   +1 more source

ROC analysis of selected matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in psoriatic patients. [PDF]

Postepy Dermatol Alergol, 2018
Glazewska EK, Niczyporuk M, Lawicki S, Szmitkowski M, Zajkowska M, Donejko M, Przylipiak A.   +6 more
europepmc   +1 more source

Tissue inhibitor of metalloproteinase-1 [PDF]

, 2018
S. Holdenrieder, P. Stieber
openaire   +1 more source

The Potential Role of Synovial T Cell Infiltration Following Knee Joint Injury in Symptoms and Progression to Osteoarthritis

Arthritis &Rheumatology, EarlyView.
Objective Identification of osteoarthritis (OA)–specific synovial inflammatory pathways and their temporal relevance is critical for therapeutic targeting. We compared mononuclear inflammatory/immune cell responses following joint injury that does or does not lead to OA to define bona fide OA‐associated cellular events.
Babak Moradi, Miriam T. Jackson, Cindy C. Shu, Susan M. Smith, Margaret M. Smith, Sanaa Zaki, Hadrian Platzer, Nils Rosshirt, David Giangreco, Carla R. Scanzello, Christopher B. Little   +10 more
wiley   +1 more source

Plasma matrix metalloproteinases and tissue inhibitors of metalloproteinases explored in relation to the severity and progression of diabetic retinopathy in patients with type 1 diabetes: baseline and prospective analyses. [PDF]

BMJ Open Ophthalmol
Hector S, Thulesius HO, Thunander M, Hillman M, Landin-Olsson M, Melin EO.   +5 more
europepmc   +1 more source

Altered Bone Mechanics, Architecture and Composition in the Skeleton of TIMP-3-Deficient Mice [PDF]

, 2017
A Bruni-Cardoso, A Carriero, A Carriero, A Carriero, A Janssen, A Ural, Adele Boskey, AL Boskey, AL Boskey, Alessandra Carriero, Andrew A. Pitsillides, B Javaheri, Behzad Javaheri, BH Weber, Brendyn Miller, CH Turner, D Stickens, E Donnelly, E Ohuchi, EL Martin, EP Paschalis, FF Mohammed, George Bou-Gharios, H Isaksson, H Zhao, HH Malluche, J Verstappen, K Bell, K Brew, K Holmbeck, K Verdelis, KJ Leco, L Hammoud, L Spevak, Lyudmila Lukashova, Lyudmila Spevak, M Federici, M Inada, M Marzia, ME Marisa, ML Bouxsein, P Garnero, PW Fedak, R Ritchie, R Shigdel, S Sahebjam, S Verrier, SE Gill, SS Apte, T Maretzky, W Cruz-Munoz, Y Shen   +51 more
core   +3 more sources

From anthelmintic to neuro‐oncology: A systematic review of mebendazole repurposing for brain tumour therapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Mebendazole (MBZ), a benzimidazole anthelmintic with established clinical use, has emerged as a repurposing candidate for primary brain tumours due to its multimodal anticancer actions and central nervous system penetrance. This systematic review synthesizes preclinical and clinical evidence evaluating MBZ's efficacy, mechanisms of action ...
Ciara B. Blum, Milli McMenamin, Tessa Khoo, John M. Edwin, Prathibha Jose, Liam A. O’Callaghan   +5 more
wiley   +1 more source

Urinary metalloproteinases and tissue inhibitors of metalloproteinases as potential early biomarkers for renal fibrosis in children with nephrotic syndrome. [PDF]

Medicine (Baltimore), 2018
Bieniaś B, Sikora P.
europepmc   +1 more source

Vitamins as potent cancer treatments through regulating the activity and expression of MMP‐2 and MMP‐9

Bulletin of the Korean Chemical Society, EarlyView.
Vitamins could regulate both MMP‐2 and MMP‐9 expression and activity through transcriptional and MAPK signaling pathway modulation. This study highlights the potential of vitamins as low‐toxicity therapeutic or adjunct agents for targeting MMP‐mediated cancer progression. Abstract Matrix metalloproteinases (MMP‐2 and MMP‐9) are key regulators of cancer
Yen Thi Nguyen, Eungchan Kim, Ha Vy Thi Vo, Song Ja Kim, Namdoo Kim, Hyuck Jin Lee   +5 more
wiley   +1 more source